Skip to main content

Advertisement

SpringerLink
Log in

Phospholipid–polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery

  • Published:
Drug Delivery and Translational Research Aims and scope Submit manuscript

Abstract

Gene silencing using small interfering RNA (siRNA) is a promising therapeutic strategy for the treatment of various diseases, in particular, cancer. Recently, our group reported on a novel gene carrier, the micelle-like nanoparticle (MNP), based on the combination of a covalent conjugate of phospholipid and polyethylenimine (PLPEI) with polyethylene glycol (PEG) and lipids. These long-circulating MNPs loaded with plasmid DNA-mediated gene expression in distal tumors after systemic administration in vivo. In the current study, we investigated the potential of MNPs for siRNA delivery. MNPs were prepared by condensing siRNA with PLPEI at a nitrogen/phosphate ratio of 10, where the binding of siRNA is complete. The addition of a PEG/lipid coating to the PLPEI complexes generated particles with sizes of ca. 200 nm and a neutral surface charge compared with positively charged PLPEI polyplexes without the additional coating. MNPs protected the loaded siRNA against enzymatic digestion and enhanced the cellular uptake of the siRNA payload. MNPs carrying green fluorescent protein (GFP)-targeted siRNA effectively downregulated the gene in cells that stably express GFP. Finally, MNPs were non-toxic at a wide range of concentrations and for different cell lines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Alshamsan A, Haddadi A, Incani V, Samuel J, Lavasanifar A, Uludag H. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine. Mol Pharmaceutics. 2009;6:121–33.

    Article  CAS  PubMed  Google Scholar 

  • Boussif O, Lezoualc’h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA. 1995;92:7297–301.

    Article  CAS  PubMed  Google Scholar 

  • Chollet P, Favrot MC, Hurbin A, Coll JL. Side-effects of a systemic injection of linear polyethylenimine–DNA complexes. J Gene Med. 2002;4:84–91.

    Article  PubMed  Google Scholar 

  • Godbey WT, Wu KK, Mikos AG. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res. 1999;45:268–75.

    Article  CAS  PubMed  Google Scholar 

  • Grayson AC, Doody AM, Putnam D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res. 2006;23:1868–76.

    Article  PubMed  Google Scholar 

  • Gusachenko O, Kravchuk Y, Konevets D, Silnikov V, Vlassov VV, Zenkova MA. Transfection efficiency of 25-kDa PEI-cholesterol conjugates with different levels of modification. J Biomater Sci. 2009;20:1091–110.

    Article  CAS  Google Scholar 

  • Han S, Mahato RI, Kim SW. Water-soluble lipopolymer for gene delivery. Bioconjug Chem. 2001;12:337–45.

    Article  CAS  Google Scholar 

  • Jeong JH, Mok H, Oh YK, Park TG. siRNA conjugate delivery systems. Bioconjug Chem. 2009;20:5–14.

    Article  CAS  PubMed  Google Scholar 

  • Kim WJ, Kim SW. Efficient siRNA delivery with non-viral polymeric vehicles. Pharm Res. 2009;26:657–66.

    Article  CAS  PubMed  Google Scholar 

  • Kim WJ, Chang CW, Lee M, Kim SW. Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy. J Control Release. 2007;118:357–63.

    Article  CAS  PubMed  Google Scholar 

  • Kircheis R, Schuller S, Brunner S, et al. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med. 1999;1:111–20.

    Article  CAS  PubMed  Google Scholar 

  • Ko YT, Bhattacharya R, Bickel U. Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting. J Control Release. 2009a;133:230–7.

    Article  CAS  PubMed  Google Scholar 

  • Ko YT, Kale A, Hartner WC, Papahadjopoulos-Sternberg B, Torchilin VP. Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery. J Control Release. 2009b;133:132–8.

    Article  CAS  PubMed  Google Scholar 

  • Kunath K, von Harpe A, Fischer D, et al. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J Control Release. 2003;89:113–25.

    Article  CAS  PubMed  Google Scholar 

  • Liu C, Zhao G, Liu J, et al. Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel. J Control Release. 2009;140:277–83.

    Article  CAS  PubMed  Google Scholar 

  • Malek A, Czubayko F, Aigner A. PEG grafting of polyethylenimine (PEI) exerts different effects on DNA transfection and siRNA-induced gene targeting efficacy. J Drug Target. 2008;16:124–39.

    Article  CAS  PubMed  Google Scholar 

  • Mao S, Neu M, Germershaus O, et al. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes. Bioconjug Chem. 2006;17:1209–18.

    Article  CAS  PubMed  Google Scholar 

  • Merdan T, Kunath K, Fischer D, Kopecek J, Kissel T. Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm Res. 2002;19:140–6.

    Article  CAS  PubMed  Google Scholar 

  • Musacchio T, Vaze O, D’Souza G, Torchilin VP. Effective stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles. Bioconjug Chem. 2010;21:1530–6.

    Article  CAS  PubMed  Google Scholar 

  • Nimesh S, Chandra R. Polyethylenimine nanoparticles as an efficient in vitro siRNA delivery system. Eur J Pharm Biopharm. 2009;73:43–9.

    Article  CAS  PubMed  Google Scholar 

  • Novina CD, Sharp PA. The RNAi revolution. Nature. 2004;430:161–4.

    Article  CAS  PubMed  Google Scholar 

  • Oh YK, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev. 2009;61:850–62.

    Article  CAS  PubMed  Google Scholar 

  • Philipp A, Zhao X, Tarcha P, Wagner E, Zintchenko A. Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery. Bioconjug Chem. 2009;20:2055–61.

    Article  CAS  PubMed  Google Scholar 

  • Rothdiener M, Muller D, Castro PG, et al. Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systems. J Control Release. 2010;144:251–8.

    Article  CAS  PubMed  Google Scholar 

  • Schafer J, Hobel S, Bakowsky U, Aigner A. Liposome–polyethylenimine complexes for enhanced DNA and siRNA delivery. Biomaterials. 2010;31:6892–900.

    Article  PubMed  Google Scholar 

  • Schroeder A, Levins CG, Cortez C, Langer R, Anderson DG. Lipid-based nanotherapeutics for siRNA delivery. J Intern Med. 2009;267:9–21.

    Article  Google Scholar 

  • Siomi H, Siomi MC. On the road to reading the RNA-interference code. Nature. 2009;457:396–404.

    Article  CAS  PubMed  Google Scholar 

  • Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 2005;12:461–6.

    Article  CAS  PubMed  Google Scholar 

  • Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009;8:129–38.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a fellowship from the Department of Education of the Navarra Regional Government (Spain) to GN.

Author information

Authors and Affiliations

  1. Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, 360 Huntington Ave, Boston, MA, 02115, USA

    Gemma Navarro, Rupa R. Sawant, Sean Essex & Vladimir P. Torchilin

  2. Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra, 31080, Pamplona, Spain

    Conchita Tros de ILarduya

Authors
  1. Gemma Navarro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rupa R. Sawant
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sean Essex
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Conchita Tros de ILarduya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vladimir P. Torchilin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vladimir P. Torchilin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Navarro, G., Sawant, R.R., Essex, S. et al. Phospholipid–polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery. Drug Deliv. and Transl. Res. 1, 25–33 (2011). https://doi.org/10.1007/s13346-010-0004-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13346-010-0004-0

Keywords

Search

Navigation